Alamar Biosciences, Inc. (ALMR) Guidance & Earnings Results
On 2026-08-10 Alamar Biosciences, Inc. raised guidance: "FY2026 revenue $116-120M, representing 59% growth at…" — from its own filing, as read by EquiReason.
Source: SEC EDGAR filings · read by EquiReason
ALMRAlamar Biosciences, Inc.Follow ALMR — free
—
Price chart with a free account
- Market cap
- 2.1B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 3 Nov, in 10 days
What management guided
each earnings 8-K · figures checked against the filing text| Release | Direction | What they said |
|---|---|---|
| 10 Aug 26 | Raised | FY2026 revenue $116-120M, representing 59% growth at midpoint · full year |
Alamar Biosciences, Inc. — questions
- What guidance did Alamar Biosciences, Inc. give?
- On 2026-08-10: "FY2026 revenue $116-120M, representing 59% growth at midpoint"
- When does Alamar Biosciences, Inc. report earnings?
- Alamar Biosciences, Inc.'s next earnings report is expected on 2026-11-03.
Every figure on this page comes from Alamar Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.